Key Drivers
- Q1 Recovery
- High Leverage
- Strong Cash Flow
AIAI Summary
Centene has shifted from a “cheap but broken” Medicaid name to a credible turnaround story after beating earnings, raising guidance, and improving medical-cost control, but the investment now hinges on whether those margin gains can hold through a policy-sensitive, highly levered balance sheet—especially after the stock's sharp run-up.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Q1 Recovery
- •High Leverage
- •Strong Cash Flow
CNC's strong Q1 margin and cash-flow rebound contrasts with a weak full-year loss, but elevated leverage and thin liquidity keep the turnaround dependent on sustained operating improvement.
Price Behavior
Key Price Behavior Insights:
- •Strong rally
- •Overbought momentum
- •Near resistance
CNC has surged sharply over the last month and remains in an uptrend, but it is now overbought and just below resistance, making a short-term pause or pullback more likely than an immediate breakout.
Sharp rally from the high $30s to the high $50s with a brief consolidation and slight cooling in the last three closes
Sentiment & News
Key News Insights:
- •Earnings Beat
- •Premium Growth
- •Cost Pressures
Centene's Q1 beat on earnings and revenue, stronger premiums, and a raised 2026 outlook drove a sharp stock jump, but membership declines and higher medical costs suggest the turnaround still needs execution.
The results are modestly bullish for Centene, but sustained upside likely depends on continued cost control and stabilization in membership trends
Similar Companies in Healthcare
Other companies in the same sector with AI ratings